Obesity-related hypertension: Possible pathophysiological mechanisms

Journal of Endocrinology

Volumn 223, Issue 3, 2014, Pages R63-R78

  Vaněčková, Ivana ^a   Maletínská, Lenka ^b   Behuliak, Michal ^a   Nagelová, Veronika ^b   Zicha, Josef ^a   Kuneš, Jaroslav ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Critical developmental periods; Epigenetics; Hypertension; Obesity; Rat; Renin angiotensin system; Sympathetic nervous system

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALDOSTERONE; CATHEPSIN; CHOLECYSTOKININ; CHYMASE; CYTOKINE; GHRELIN; INSULIN; LEPTIN; LIPID; PEPTIDE; PROOPIOMELANOCORTIN;

ABDOMINAL OBESITY; ADRENERGIC SYSTEM; ADULTHOOD; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; CARDIOVASCULAR DISEASE; DECREASED APPETITE; DYSLIPIDEMIA; EARLY DIAGNOSIS; ENERGY EXPENDITURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION; GENETICS; GLUCOSE INTOLERANCE; HEART RATE VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC RATE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ONTOGENY; PARASYMPATHETIC TONE; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PLASMA RENIN ACTIVITY; PRENATAL STRESS; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; VASCULAR RESISTANCE; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL MODEL; BLOOD PRESSURE; MULTIFACTORIAL INHERITANCE;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; MULTIFACTORIAL INHERITANCE; OBESITY; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 84911972641     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0368     Document Type: Article

References (172)

1. Agapitov AV, Correia ML, Sinkey CA & Haynes WG 2008 Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 52 687-695. (doi:10.1161/HYPERTENSIONAHA.107.109603)
2. Aghamohammadzadeh R & Heagerty AM 2012 Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Annals of Medicine 44(Suppl 1) S74-S84. (doi:10.3109/07853890.2012.663928)
3. Aguilera CM, Olza J & Gil A 2013 Genetic susceptibility to obesity and metabolic syndrome in childhood. Nutrición Hospitalaria 28(Suppl 5) 44-55.
4. Allemann Y, Hutter D, Aeschbacher BC, Fuhrer J, Delacrétaz E & Weidmann P 2001 Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study. Journal of Hypertension 19 2143-2148. (doi:10.1097/00004872-200112000-00005)
5. Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K & Head GA 2012 Rapid onset of renal sympathetic nerve activation in rabbits fed a highfat diet. Hypertension 60 163-171. (doi:10.1161/HYPERTENSIONAHA. 111.190413)
6. de Artiñano A & Castro M 2009 Experimental rat models to study the metabolic syndrome. British Journal of Nutrition 102 1246-1253. (doi:10.1017/S0007114509990729)
7. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, Moizo L, Lehy T, Guerre-Millo M, Le Marchand-Brustel Y et al. 1998 The stomach is a source of leptin. Nature 394 790-793. (doi:10.1038/29547)
8. Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F & Zamboulis C 2008 Neuropeptide Y and α-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. International Journal of Clinical Practice 62 1432-1440. (doi:10.1111/j.1742-1241.2008.01823.x)
9. Barker DJ & Osmond C 1986 Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1 1077-1081. (doi:10.1016/S0140-6736(86)91340-1)
10. Barker DJ & Osmond C 1988 Low birth weight and hypertension. BMJ 297 134-135. (doi:10.1136/bmj.297.6641.134-b)
11. Barker DJ, Bull AR, Osmond C & Simmonds SJ 1990 Fetal and placental size and risk of hypertension in adult life. BMJ 301 259-262. (doi:10.1136/bmj.301.6746.259)
12. Bell CG, Walley AJ & Froguel P 2005 The genetics of human obesity. Nature Reviews. Genetics 6 221-234. (doi:10.1038/nrg1556)
13. Benediktsson R, Lindsay RS, Noble J, Seckl JR & Edwards CR 1993 Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341 339-341. (doi:10.1016/0140-6736(93)90138-7)
14. Bertram C, Trowern AR, Copin N, Jackson AA & Whorwood CB 2001 The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11 β-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 142 2841-2853. (doi:10.1210/en. 142.7.2841)
15. Beske SD, Alvarez GE, Ballard TP & Davy KP 2002 Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. American Journal of Physiology. Heart and Circulatory Physiology 282 H630-H635. (doi:10.1152/ajpheart.00642.2001)
16. Bogdarina I, Welham S, King PJ, Burns SP & Clark AJ 2007 Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research 100 520-526. (doi:10.1161/01. RES.0000258855.60637.58)
17. Bouret SG 2009 Early life origins of obesity: role of hypothalamic programming. Journal of Pediatric Gastroenterology and Nutrition 48(Suppl 1) S31-S38. (doi:10.1097/MPG.0b013e3181977375)
18. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC & Cassis LA 2004 Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287 R943-R949. (doi:10.1152/ajpregu.00265.2004)
19. Boustany CM, Brown DR, Randall DC & Cassis LA 2005 AT1-receptor antagonism reverses the blood pressure elevation associated with dietinduced obesity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 289 R181-R186. (doi:10.1152/ajpregu.00507.2004)
20. Bray GA 2000 Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. International Journal of Obesity and Related Metabolic Disorders 24(Suppl 2) S8-S17. (doi:10.1038/sj.ijo.0801269)
21. Callaghan B, Hunne B, Hirayama H, Sartor DM, Nguyen TV, Abogadie FC, Ferens D, McIntyre P, Ban K, Baell J et al. 2012 Sites of action of ghrelin receptor ligands in cardiovascular control. American Journal of Physiology. Heart and Circulatory Physiology 303 H1011-H1021. (doi:10.1152/ajpheart.00418.2012)
22. Callaghan B, Kosari S, Pustovit RV, Sartor DM, Ferens D, Ban K, Baell J, Nguyen TV, Rivera LR, Brock JA et al. 2014 Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor. British Journal of Pharmacology 171 1275-1286. (doi:10.1111/bph.12527)
23. Campbell DJ & Habener JF 1987 Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121 1616-1626. (doi:10.1210/endo-121-5-1616)
24. Canale MP, Manca di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo A & Di Daniele N 2013 Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. International Journal of Endocrinology 2013 865965. (doi:10.1155/2013/865965)
25. Cao J, Sodhi K, Puri N, Monu SR, Rezzani R & Abraham NG 2011 High fat diet enhances cardiac abnormalities in SHR rats: protective role of heme oxygenase-adiponectin axis. Diabetology & Metabolic Syndrome 3 37. (doi:10.1186/1758-5996-3-37)
26. Carlyle M, Jones OB, Kuo JJ & Hall JE 2002 Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39 496-501. (doi:10.1161/hy0202.104398)
27. do Carmo JM, da Silva AA, Rushing JS & Hall JE 2012 Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 302 R561-R567. (doi:10.1152/ajpregu.00392.2011)
28. do Carmo JM, da Silva AA, Sessums PO, Ebaady SH, Pace BR, Rushing JS, Davis MT & Hall JE 2014 Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. International Journal of Obesity 38 775-783. (doi:10.1038/ijo.2013.177)
29. Cassis LA, Lynch KR & Peach MJ 1988 Localization of angiotensinogen messenger RNA in rat aorta. Circulation Research 62 1259-1262. (doi:10.1161/01.RES.62.6.1259)
30. Cassis LA, Police SB, Yiannikouris F & Thatcher SE 2008 Local adipose tissue renin-angiotensin system. Current Hypertension Reports 10 93-98. (doi:10.1007/s11906-008-0019-9)
31. Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH et al. 2010 Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Nephrology, Dialysis, Transplantation 25 389-399. (doi:10.1093/ndt/gfp472)
32. Cooney CA, Dave AA & Wolff GL 2002 Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. Journal of Nutrition 132 2393S-2400S.
33. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI & Mark AL 2002 The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51 439-442. (doi:10.2337/diabetes.51.2.439)
34. Darnaudéry M & Maccari S 2008 Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Research Reviews 57 571-585. (doi:10/1016/j.brainresrev.2007.11.004)
35. Davy KP & Orr JS 2009 Sympathetic nervous system behavior in human obesity. Neuroscience and Biobehavioral Reviews 33 116-124. (doi:10.1016/j.neubiorev.2008.05.024)
36. Di Chiara T, Argano C, Corrao S, Scaglione R & Licata G 2012 Hypoadiponectinemia: a link between visceral obesity and metabolic syndrome. Journal of Nutrition and Metabolism 2012 175245. (doi:10.1155/2012/175245)
37. Dobrian AD, Davies MJ, Prewitt RL & Lauterio TJ 2000 Development of hypertension in a rat model of diet-induced obesity. Hypertension 35 1009-1015. (doi:10.1161/01.HYP.35.4.1009)
38. Dodic M, Hantzis V, Duncan J, Rees S, Koukoulas I, Johnson K, Wintour EM & Moritz K 2002 Programming effects of short prenatal exposure to cortisol. FASEB Journal 16 1017-1026. (doi:10.1096/fj.01-1045com)
39. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA et al. 2006 DNA methylation profiling of human chromosomes 6, 20 and 22. Nature Genetics 38 1378-1385. (doi:10.1038/ng1909)
40. Egger G, Liang G, Aparicio A & Jones PA 2004 Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 457-463. (doi:10.1038/nature02625)
41. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, Zhu J, Carlson S, Helgason A, Walters GB, Gunnarsdottir S et al. 2008 Genetics of gene expression and its effect on disease. Nature 452 423-428. (doi:10.1038/nature06758)
42. Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC & Sharma AM 2005 Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45 356-362. (doi:10.1161/01.HYP.0000154361. 47683.d3)
43. Erhuma A, McMullen S, Langley-Evans SC & Bennett AJ 2009 Feeding pregnant rats a low-protein diet alters the hepatic expression of SREBP- 1c in their offspring via a glucocorticoid-related mechanism. Endocrine 36 333-338. (doi:10.1007/s12020-009-9225-8)
44. Ernsberger P, Johnson JL, Rosenthal T, Mirelman D & Koletsky RJ 2007 Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. American Journal of Hypertension 20 866-874. (doi:10.1016/j.amjhyper.2007.02.015)
45. Falaschetti E, Hingorani AD, Jones A, Charakida M, Finer N, Whincup P, Lawlor DA, Davey Smith G, Sattar N & Deanfield JE 2010 Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children. European Heart Journal 31 3063-3072. (doi:10.1093/eurheartj/ehq355)
46. Feinberg AP 2008 Epigenetics at the epicenter of modern medicine. Journal of the American Medical Association 299 1345-1350. (doi:10.1001/jama.299.11.1345)
47. Fellmann L, Nascimento AR, Tibiriça E & Bousquet P 2013 Murine models for pharmacological studies of the metabolic syndrome. Pharmacology & Therapeutics 137 331-340. (doi:10.1016/j.pharmthera.2012.11.004)
48. Friedman JE, de Venté JE, Peterson RG & Dohm GL 1991 Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). American Journal of Physiology 261 E782-E788.
49. Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Kaung HL & Ernsberger P 1997 Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. American Journal of Physiology 273 E1014-E1023.
50. Gallou-Kabani C & Junien C 2005 Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes 54 1899-1906. (doi:10.2337/diabetes.54.7.1899)
51. Gluckman PD, Lillycrop KA, Vickers MH, Pleasants AB, Phillips ES, Beedle AS, Burdge GC & Hanson MA 2007 Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. PNAS 104 12796-12800. (doi:10.1073/pnas.0705667104)
52. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F & Mancia G 1995 Sympathetic activation in obese normotensive subjects. Hypertension 25 560-563. (doi:10.1161/01.HYP.25.4.560)
53. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB & Mancia G 2004 Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. Journal of Hypertension 22 2363-2369. (doi:10.1097/00004872-200412000-00019)
54. Hall JE 2003 The kidney, hypertension, and obesity. Hypertension 41 625-633. (doi:10.1161/01.HYP.0000052314.95497.78)
55. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA & Gaillard CA 1990 Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines? Hypertension 15 519-527. (doi:10.1161/01.HYP.15.5.519)
56. Hall JE, Hildebrandt DA & Kuo J 2001 Obesity hypertension: role of leptin and sympathetic nervous system. American Journal of Hypertension 14 103S-115S. (doi:10.1016/S0895-7061(01)02077-5)
57. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G & Stec DE 2010 Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. Journal of Biological Chemistry 285 17271-17276. (doi:10.1074/jbc.R110.113175)
58. Hamdy O, Porramatikul S & Al-Ozairi E 2006 Metabolic obesity: the paradox between visceral and subcutaneous fat. Current Diabetes Reviews 2 367-373. (doi:10.2174/1573399810602040367)
59. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL & Haynes WG 2002 Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. Journal of Hypertension 20 1633-1641. (doi:10.1097/00004872-200208000-00027)
60. Hilzendeger AM, Morgan DA, Brooks L, Dellsperger D, Liu X, Grobe JL, Rahmouni K, Sigmund CD & Mark AL 2012 A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. American Journal of Physiology. Heart and Circulatory Physiology 303 H197-H206. (doi:10.1152/ajpheart.00974.2011)
61. Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, Suzuki S, Takaya N, Nakagawa T, Fukui T et al. 2012 Reduction of visceral fat correlates with the decrease in the number of obesity-related cardiovascular risk factors in Japanese with Abdominal Obesity (VACATION-J Study). Journal of Atherosclerosis and Thrombosis 19 1006-1018. (doi:10.5551/jat.12963)
62. Hofmann M, Pollow K, Bahlmann F, Casper F, Steiner E & Brockerhoff P 2001 11β-hydroxysteroid dehydrogenase (11β-HSD-II) activity in human placenta: its relationship to placental weight and birth weight and its possible role in hypertension. Journal of Perinatal Medicine 29 23-30. (doi:10.1515/JPM.2001.003)
63. Holmes MC, Yau JL, Kotelevtsev Y, Mullins JJ & Seckl JR 2003 11β-hydroxysteroid dehydrogenases in the brain: two enzymes two roles. Annals of the New York Academy of Sciences 1007 357-366. (doi:10.1196/annals.1286.035)
64. Huber DA & Schreihofer AM 2010 Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms. Journal of Physiology 588 1515-1525. (doi:10.1113/jphysiol.2009. 186387)
65. Huber DA & Schreihofer AM 2011 Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats. American Journal of Physiology. Heart and Circulatory Physiology 301 H230-H240. (doi:10.1152/ajpheart.00075.2011)
66. Inagami T 1995 Recent progress in molecular and cell biological studies of angiotensin receptors. Current Opinion in Nephrology and Hypertension 4 47-54. (doi:10.1097/00041552-199501000-00007)
67. Julius S, Valentini M & Palatini P 2000 Overweight and hypertension: a 2-way street? Hypertension 35 807-813. (doi:10.1161/01.HYP.35.3.807)
68. Kalil GZ & Haynes WG 2012 Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertension Research 35 4-16. (doi:10.1038/hr.2011.173)
69. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH & Kelber S 1983 Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. Journal of Laboratory and Clinical Medicine 102 621-627.
70. Kalupahana NS & Moustaid-Moussa N 2012 The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obesity Reviews 13 136-149. (doi:10.1111/j.1467-789X.2011.00942.x)
71. Kannel WB 2000 Fifty years of Framingham Study contributions to understanding hypertension. Journal of Human Hypertension 14 83-90. (doi:10.1038/sj.jhh.1000949)
72. Karlsson C, Lindell K, Ottosson M, Sjöström L, Carlsson B & Carlsson LM 1998 Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. Journal of Clinical Endocrinology and Metabolism 83 3925-3929. (doi:10.1210/jc.83. 11.3925)
73. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE & Granger JP 1995 Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25 893-897. (doi:10.1161/01.HYP.25.4.893)
74. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK & Adams PW 1982 Relation of body fat distribution to metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism 54 254-260. (doi:10.1210/jcem-54-2-254)
75. Knight SF, Quigley JE, Yuan J, Roy SS, Elmarakby A & Imig JD 2008 Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 51 352-359. (doi:10.1161/HYPERTENSIONAHA.107.099499)
76. Koletsky S 1975 Pathologic findings and laboratory data in a new strain of obese hypertensive rats. American Journal of Pathology 80 129-142.
77. Korner PI 2007 Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms, pp 408-409. Oxford: Oxford University Press.
78. Kotsis V, Stabouli S, Papakatsika S, Rizos Z & Parati G 2010 Mechanisms of obesity-induced hypertension. Hypertension Research 33 386-393. (doi:10.1038/hr.2010.9)
79. Kouzarides T 2007 Chromatin modifications and their function. Cell 128 693-705. (doi:10.1016/j.cell.2007.02.005)
80. Kuneš J & Zicha J 2006 Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clinical Science 111 295-305. (doi:10.1042/CS20050271)
81. Kuneš J & Zicha J 2009 The interaction of genetic and environmental factors in the etiology of hypertension. Physiological Research 58(Suppl 2) S33-S41.
82. Kuneš J, Kadlecová M, Vaněčková I & Zicha J 2012 Critical developmental periods in the pathogenesis of hypertension. Physiological Research 61(Suppl 1) S9-S17.
83. Kurtz TW, Morris RC & Pershadsingh HA 1989 The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13 896-901. (doi:10.1161/01.HYP.13.6.896)
84. Kuzawa CW & Sweet E 2009 Epigenetics and the embodiment of race: developmental origins of US racial disparities in cardiovascular health. American Journal of Human Biology 21 2-15. (doi:10.1002/ajhb.20822)
85. Laederach-Hofmann K, Mussgay L & Rúddel H 2000 Autonomic cardiovascular regulation in obesity. Journal of Endocrinology 164 59-66. (doi:10.1677/joe.0.1640059)
86. Lambert GW, Straznicky NE, Lambert EA, Dixon JB & Schlaich MP 2010 Sympathetic nervous activation in obesity and themetabolic syndrome - causes, consequences and therapeutic implications. Pharmacology & Therapeutics 126 159-172. (doi:10.1016/j.pharmthera.2010.02.002)
87. Landsberg L 1986 Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Quarterly Journal of Medicine 61 1081-1090.
88. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D & Sowers J 2013 Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. Journal of Clinical Hypertension 15 14-33. (doi:10.1111/jch.12049)
89. Langley-Evans SC 1996 Intrauterine programming of hypertension in the rat: nutrient interactions. Comparative Biochemistry and Physiology. Part A, Physiology 114 327-333. (doi:10.1016/0300-9629(96)00018-7)
90. Langley-Evans SC 1997 Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. Journal of Hypertension 15 537-544. (doi:10.1097/00004872-199715050-00010)
91. Langley-Evans SC 2006 Developmental programming of health and disease. Proceedings of the Nutrition Society 65 97-105. (doi:10.1079/PNS2005478)
92. Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CR, Jackson AA & Seckl JR 1996 Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 17 169-172. (doi:10.1016/S0143-4004(96)80010-5)
93. Lillycrop KA & Burdge GC 2012 Epigenetic mechanisms linking early nutrition to long term health. Best Practice & Research. Clinical Endocrinology & Metabolism 26 667-676. (doi:10.1016/j.beem. 2012.03.009)
94. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA & Burdge GC 2005 Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. Journal of Nutrition 135 1382-1386.
95. Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA & Burdge GC 2007 Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. British Journal of Nutrition 97 1064-1073. (doi:10.1017/S000711450769196X)
96. Lillycrop KA, Phillips ES, Torrens C, Hanson MA, Jackson AA & Burdge GC 2008 Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPARa promoter of the offspring. British Journal of Nutrition 100 278-282. (doi:10.1017/S0007114507894438)
97. Lithell H, Pollare T, Berne C & Saltin B 1992 The metabolic and circulatory response to β-blockade in hypertensive men is correlated to muscle capillary density. Blood Pressure 1 20-26. (doi:10.3109/ 08037059209065120)
98. Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C & Irwin ED 2012 Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension 59 331-338. (doi:10.1161/HYPERTENSIONAHA.111. 185074)
99. Mark AL 2013 Selective leptin resistance revisited. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 305 R566-R581. (doi:10.1152/ajpregu.00180.2013)
100. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD & Haynes WG 1999 Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. Journal of Hypertension 17 1949-1953. (doi:10.1097/00004872-199917121-00026)
101. Mark AL, Correia ML, Rahmouni K & Haynes WG 2002 Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. Journal of Hypertension 20 1245-1250. (doi:10.1097/ 00004872-200207000-00001)
102. Mark AL, Correia ML, Rahmouni K & Haynes WG 2004 Loss of leptin actions in obesity: two concepts with cardiovascular implications. Clinical and Experimental Hypertension 26 629-636. (doi:10.1081/CEH-200031948)
103. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J et al. 2001 Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB Journal 15 2727-2729. (doi:10.1096/fj.01-0457fje)
104. Matsumura K, Tsuchihashi T, Fujii K & Iida M 2003 Neural regulation of blood pressure by leptin and the related peptides. Regulatory Peptides 114 79-86. (doi:10.1016/S0167-0115(03)00116-2)
105. Matsuzawa Y, Funahashi T & Nakamura T 2011 The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Journal of Atherosclerosis and Thrombosis 18 629-639. (doi:10.5551/jat.7922)
106. McMullen S & Langley-Evans SC 2005 Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 R85-R90. (doi:10.1152/ajpregu.00435.2004)
107. Mehler MF 2008 Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Progress in Neurobiology 86 305-341. (doi:10.1016/j.pneurobio.2008.10.001)
108. Messerli FH, Christie B, DeCarvalho JG, Aristimuno GG, Suarez DH, Dreslinski GR & Frohlich ED 1981 Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Archives of Internal Medicine 141 81-85. (doi:10.1001/archinte.1981.00340010073016)
109. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A & Fuchs Z 1985 Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. Journal of Clinical Investigation 75 809-817. (doi:10.1172/JCI111776)
110. Morgan DA, Anderson EA & Mark AL 1995 Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 25 834-838. (doi:10.1161/01.HYP.25.4.834)
111. Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H et al. 2011 Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nature Medicine 17 573-580. (doi:10.1038/nm.2337)
112. Must A, Spadano J, Coakley EH, Field AE, Colditz G & Dietz WH 1999 The disease burden associated with overweight and obesity. Journal of the American Medical Association 282 1523-1529. (doi:10.1001/jama. 282.16.1523)
113. Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R & Law CM 2003 Is birth weight related to later glucose and insulin metabolism? A systematic review Diabetic Medicine 20 339-348. (doi:10.1046/j.1464-5491.2003.00871.x)
114. Nyirenda MJ & Seckl JR 1998 Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure (Review). International Journal of Molecular Medicine 2 607-614. (doi:10.3892/ijmm.2.5.607)
115. Ordovás JM & Smith CE 2010 Epigenetics and cardiovascular disease. Nature Reviews. Cardiology 7 510-519. (doi:10.1038/nrcardio.2010.104)
116. Paul M, Poyan Mehr A & Kreutz R 2006 Physiology of local renin-angiotensin systems. Physiological Reviews 86 747-803. (doi:10.1152/physrev.00036.2005)
117. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, Barker DJ & Whorwood CB 2000 Low birth weight predicts elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 35 1301-1306. (doi:10.1161/01.HYP.35.6.1301)
118. Piccirillo G, Vetta F, Viola E, Santagada E, Ronzoni S, Cacciafesta M & Marigliano V 1998 Heart rate and blood pressure variability in obese normotensive subjects. International Journal of Obesity and Related Metabolic Disorders 22 741-750. (doi:10.1038/sj.ijo.0800650)
119. Pinheiro AR, Salvucci ID, Aguila MB & Mandarim-de-Lacerda CA 2008 Protein restriction during gestation and/or lactation causes adverse transgenerational effects on biometry and glucose metabolism in F1 and F2 progenies of rats. Clinical Science 114 381-392. (doi:10.1042/CS20070302)
120. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B & Head GA 2010 Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 55 862-868. (doi:10.1161/HYPERTENSIONAHA. 109.141119)
121. Ptak C & Petronis A 2008 Epigenetics and complex disease: from etiology to new therapeutics. Annual Review of Pharmacology and Toxicology 48 257-276. (doi:10.1146/annurev.pharmtox.48.113006.094731)
122. Rahmouni K & Morgan DA 2007 Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin. Hypertension 49 647-652. (doi:10.1161/01.HYP.0000254827.59792.b2)
123. Rahmouni K, Haynes WG, Morgan DA & Mark AL 2002 Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 39 486-490. (doi:10.1161/hy0202.102836)
124. Rahmouni K, Haynes WG, Morgan DA & Mark AL 2003 Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. Journal of Neuroscience 23 5998-6004.
125. Rahmouni K, Morgan DA, Morgan GM, Mark AL & Haynes WG 2005a Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54 2012-2018. (doi:10.2337/diabetes.54.7.2012)
126. Rahmouni K, Correia ML, Haynes WG & Mark AL 2005b Obesity-associated hypertension: new insights into mechanisms. Hypertension 45 9-14. (doi:10.1161/01.HYP.0000151325.83008.b4)
127. Reik W, Dean W & Walter J 2001 Epigenetic reprogramming in mammalian development. Science 293 1089-1093. (doi:10.1126/science.1063443)
128. Rocchini AP, Yang JQ & Gokee A 2004 Hypertension and insulin resistance are not directly related in obese dogs. Hypertension 43 1011-1016. (doi:10.1161/01.HYP.0000123073.48855.e9)
129. Roche HM, Phillips C & Gibney MJ 2005 The metabolic syndrome: the crossroads of diet and genetics. Proceedings of the Nutrition Society 64 371-377. (doi:10.1079/PNS2005445)
130. Russell JC & Proctor SD 2006 Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovascular Pathology 15 318-330. (doi:10.1016/j.carpath.2006.09.001)
131. Russo P, Lauria F & Siani A 2010 Heritability of body weight: moving beyond genetics. Nutrition, Metabolism, and Cardiovascular Diseases 20 691-697. (doi:10.1016/j.numecd.2010.09.007)
132. Sakaguchi T, Takahashi M & Bray GA 1988 Diurnal changes in sympathetic activity. Relation to food intake and to insulin injected into the ventromedial or suprachiasmatic nucleus. Journal of Clinical Investigation 82 282-286. (doi:10.1172/JCI113584)
133. Sartor DM 2013 Sympathoinhibitory signals from the gut and obesity-related hypertension. Clinical Autonomic Research 23 33-39. (doi:10.1007/s10286-012-0171-9)
134. Šedová L, Bérubé J, Gaudet D, Dumont M, Tremblay J, Hamet P & Pausová Z 2004 Diet-induced obesity delays cardiovascular recovery from stress in spontaneously hypertensive rats. Obesity Research 12 1951-1958. (doi:10.1038/oby.2004.245)
135. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN & Biaggioni I 2007 Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49 27-33. (doi:10.1161/01.HYP.0000251679.87348.05)
136. Shinde UA, Desai KM, Yu C & Gopalakrishnan V 2005 Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels. Journal of Hypertension 23 779-784. (doi:10.1097/01.hjh.0000163146.20330.bc)
137. da Silva AA, Kuo JJ & Hall JE 2004 Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43 1312-1317. (doi:10.1161/01. HYP.0000128421.23499.b9)
138. da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E & Hall JE 2008 Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 51 884-890. (doi:10.1161/HYPERTENSIONAHA.107. 100636)
139. da Silva AA, do Carmo J, Dubinion J & Hall JE 2009 The role of the sympathetic nervous system in obesity-related hypertension. Current Hypertension Reports 11 206-211. (doi:10.1007/s11906-009-0036-3)
140. da Silva AA, do Carmo JM, Wang Z & Hall JE 2014 The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology 29 196-202. (doi:10.1152/physiol.00061.2013)
141. Spotswood HT & Turner BM 2002 An increasingly complex code. Journal of Clinical Investigation 110 577-582. (doi:10.1172/JCI0216547)
142. Stocker CJ, Arch JR & Cawthorne MA 2005 Fetal origins of insulin resistance and obesity. Proceedings of the Nutrition Society 64 143-151. (doi:10.1079/PNS2005417)
143. Stokes J III, Kannel WB, Wolf PA, D'Agostino RB & Cupples LA 1989 Blood pressure as a risk factor for cardiovascular disease. The Framingham Study - 30 years of follow-up. Hypertension 13 I13-I18. (doi:10.1161/ 01.HYP.13.5_Suppl.I13)
144. Sweeney G 2010 Cardiovascular effects of leptin. Nature Reviews. Cardiology 7 22-29. (doi:10.1038/nrcardio.2009.224)
145. Tallam LS, da Silva AA & Hall JE 2006 Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48 58-64. (doi:10.1161/01.HYP.0000227966.36744.d9)
146. Taylor PD & Poston L 2007 Developmental programming of obesity in mammals. Experimental Physiology 92 287-298. (doi:10.1113/expphysiol. 2005.032854)
147. Tentolouris N, Tsigos C, Perea D, Koukou E, Kyriaki D, Kitsou E, Daskas S, Daifotis Z, Makrilakis K, Raptis SA et al. 2003 Differential effects of highfat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism 52 1426-1432. (doi:10.1016/S0026-0495(03)00322-6)
148. Thatcher S, Yiannikouris F, Gupte M & Cassis L 2009 The adipose renin-angiotensin system: role in cardiovascular disease. Molecular and Cellular Endocrinology 302 111-117. (doi:10.1016/j.mce.2009.01.019)
149. Torrens C, Poston L & Hanson MA 2008 Transmission of raised blood pressure and endothelial dysfunction to the F2 generation induced by maternal protein restriction in the F0, in the absence of dietary challenge in the F1 generation. British Journal of Nutrition 100 760-766. (doi:10.1017/S0007114508921747)
150. Townsend RR & Klein S 1997 Lipolytic sensitivity and response to fasting in normotensive and hypertensive obese humans. Metabolism 46 1080-1084. (doi:10.1016/S0026-0495(97)90282-1)
151. Turunen MP, Lehtola T, Heinonen SE, Assefa GS, Korpisalo P, Girnary R, Glass CK, Väisänen S & Ylä-Herttuala S 2009 Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circulation Research 105 604-609. (doi:10.1161/CIRCRESAHA.109.200774)
152. Vague J 1956 The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. American Journal of Clinical Nutrition 4 20-34.
153. Varga O, Harangi M, Olsson IA & Hansen AK 2010 Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obesity Reviews 11 792-807. (doi:10.1111/j.1467-789X.2009. 00667.x)
154. Vaz M, Jennings G, Turner A, Cox H, Lambert G & Esler M 1997 Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96 3423-3429. (doi:10.1161/01.CIR.96.10.3423)
155. Veenendaal MV, Painter RC, de Rooij SR, Bossuyt PM, van der Post JA, Gluckman PD, Hanson MA & Roseboom TJ 2013 Transgenerational effects of prenatal exposure to the 1944-45 Dutch famine. BJOG: an International Journal of Obstetrics and Gynaecology 120 548-553. (doi:10.1111/1471-0528.12136)
156. Velliquette RA, Koletsky RJ & Ernsberger P 2002 Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X. Experimental Biology and Medicine 227 164-170.
157. Vickers SP, Jackson HC & Cheetham SC 2011 The utility of animal models to evaluate novel anti-obesity agents. British Journal of Pharmacology 164 1248-1262. (doi:10.1111/j.1476-5381.2011.01245.x)
158. Waterland RA & Michels KB 2007 Epigenetic epidemiology of the developmental origins hypothesis. Annual Review of Nutrition 27 363-388. (doi:10.1146/annurev.nutr.27.061406.093705)
159. WHO 2000 Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 894 i-xii, 1-253.
160. Wofford MR, Anderson DC Jr, Brown CA, Jones DW, Miller ME & Hall JE 2001 Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects. American Journal of Hypertension 14 694-698. (doi:10.1016/S0895-7061(01)01293-6)
161. Wong AH, Gottesman II & Petronis A 2005 Phenotypic differences in genetically identical organisms: the epigenetic perspective. Human Molecular Genetics 14 R11-R18. (doi:10.1093/hmg/ddi116)
162. Yach D, Stuckler D & Brownell KD 2006 Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine 12 62-66. (doi:10.1038/nm0106-62)
163. Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y & Iwao H 1997 Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 29 728-735. (doi:10.1161/01.HYP.29.3.728)
164. Yasue S, Masuzaki H, Okada S, Ishii T, Kozuka C, Tanaka T, Fujikura J, Ebihara K, Hosoda K, Katsurada A et al. 2010 Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. American Journal of Hypertension 23 425-431. (doi:10.1038/ajh.2009.263)
165. Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A & Cassis LA 2012a Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 302 R244-R251. (doi:10.1152/ajpregu.00323.2011)
166. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, Daugherty A & Cassis LA 2012b Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 60 1524-1530. (doi:10.1161/HYPERTENSIONAHA.112.192690)
167. Young JB & Landsberg L 1980 Impaired suppression of sympathetic activity during fasting in the gold thioglucose-treated mouse. Journal of Clinical Investigation 65 1086-1094. (doi:10.1172/JCI109761)
168. Zambrano E, Martínez-Samayoa PM, Bautista CJ, Deás M, Guillén L, Rodríguez-González GL, Guzmán C, Larrea F & Nathanielsz PW 2005 Sex differences in transgenerational alterations of growth and metabolism in progeny (F2) of female offspring (F1) of rats fed a low protein diet during pregnancy and lactation. Journal of Physiology 566 225-236. (doi:10.1113/jphysiol.2005.086462)
169. Zhang G, Yin X, Qi Y, Pendyala L, Chen J, Hou D & Tang C 2010 Ghrelin and cardiovascular diseases. Current Cardiology Reviews 6 62-70. (doi:10.2174/157340310790231662)
170. Zicha J & Kuneš J 1999 Ontogenetic aspects of hypertension development: analysis in the rat. Physiological Reviews 79 1227-1282.
171. Zicha J, Kuneš J & Jelínek J 1986 Experimental hypertension in young and adult animals. Hypertension 8 1096-1104. (doi:10.1161/01.HYP. 8.12.1096)
172. Zucker LM & Zucker TF 1961 Fatty, a new mutation in the rat. Journal of Heredity 52 275-278.